EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Newborn screening analytes and structural birth defects among 27,000 newborns

Philip J Lupo iD, Natalie P Archer, Rachel D Harris, Lisa K Marengo, Jeremy M Schraw, Adrienne T Hoyt, Susan Tanksley, Rachel Lee, Margaret Drummond-Borg, Debra Freedenberg, Priya B Shetty iD, A J Agopian und 4 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0304238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Philip J Lupo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas. Hauptthemen laut MEDLINE: Neonatal Screening, Congenital Abnormalities. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCBDD CDC HHS, NICHD NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging evidence suggests newborn screening analytes may yield insights into the etiologies of birth defects, yet no effort has evaluated associations between a range of newborn screening analytes and birth defects.

Methods

This population-based study pooled statewide data on birth defects, birth certificates, and newborn screening analytes from Texas occurring between January 1, 2007 and December 31, 2009. Associations between a panel of thirty-six newborn screening analytes, collected by the statewide Texas Newborn Screening Program, and the presence of a birth defect, defined as at least one of 39 birth defects diagnoses recorded by the Texas Birth Defects Registry, were assessed using regression analysis.

Findings

Of the 27,643 births identified, 20,205 had at least one of the 39 birth defects of interest (cases) as identified by the Texas Birth Defects Registry, while 7,438 did not have a birth defect (controls). Among 1,404 analyte-birth defect associations evaluated, 377 were significant in replication analysis. Analytes most consistently associated with birth defects included the phenylalanine/tyrosine ratio (N = 29 birth defects), tyrosine (N = 28 birth defects), and thyroxine (N = 25 birth defects). Birth defects most frequently associated with a range of analytes included gastroschisis (N = 29 analytes), several cardiovascular defects (N = 26 analytes), and spina bifida (N = 23 analytes).

Conclusions

Several significant and novel associations were observed between newborn screening analytes and birth defects. While some findings could be consequences of the defects themselves or to the care provided to infants with these defects, these findings could help to elucidate mechanisms underlying the etiology of some birth defects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningCongenital AbnormalitiesHumansInfant, NewbornTexasFemaleRegistriesMale

Autor:innen und Institutionen

  • Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas.
  • Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, Texas.
  • Birth Defects Epidemiology and Surveillance Branch, Environmental Epidemiology and Disease Registries Section, Texas Department of State and Health Services, Austin, Texas.
  • Department of Health and Human Performance, University of Houston, Houston, Texas.
  • Laboratory Services Section, Texas Department of State Health Services, Austin, Texas.
  • Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas Health Science Center at Houston (UTHealth) School of Public Health, Houston, Texas.

ORCID-Profile: Philip J Lupo, Priya B Shetty, Charles Shumate

Förderung

  • NCBDD CDC HHS
  • NICHD NIH HHS
  • NCI NIH HHS
  • NEI NIH HHS
  • National Center on Birth Defects and Developmental Disabilities
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institute of Health (NIH) National Eye Institute
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Lupo, P. J., Archer, N. P., Harris, R. D., Marengo, L. K., Schraw, J. M., Hoyt, A. T., Tanksley, S., Lee, R., Drummond-Borg, M., Freedenberg, D., Shetty, P. B., Agopian, A. J., Shumate, C., Rasmussen, S. A., Langlois, P. H., & Canfield, M. A. (2024). Newborn screening analytes and structural birth defects among 27,000 newborns. PLOS ONE. https://doi.org/10.1371/journal.pone.0304238

Vancouver

Lupo PJ, Archer NP, Harris RD, Marengo LK, Schraw JM, Hoyt AT, et al. Newborn screening analytes and structural birth defects among 27,000 newborns. PLOS ONE. 2024. doi:10.1371/journal.pone.0304238

BibTeX
@article{Lupo2024,
  author = {Lupo, Philip J and Archer, Natalie P and Harris, Rachel D and Marengo, Lisa K and Schraw, Jeremy M and Hoyt, Adrienne T and Tanksley, Susan and Lee, Rachel and Drummond-Borg, Margaret and Freedenberg, Debra and Shetty, Priya B and Agopian, A J and Shumate, Charles and Rasmussen, Sonja A and Langlois, Peter H and Canfield, Mark A},
  title = {Newborn screening analytes and structural birth defects among 27,000 newborns},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0304238}
}
Kostenlos starten →